Medicaid

Press Release: Late-breaking Dupixent® (dupilumab) data at ERS 2022 show consistent efficacy and safety profile for up to two years in children aged 6 to 11 years with moderate-to-severe asthma

InvestmentPitch Media Video Discusses Reliq Health, a Rapidly Growing Global Telemedicine Company, Signs Five New Contracts, Adding more than 10,000 New Patients to its iUGO Care Platform

VANCOUVER, British Columbia, Aug. 22, 2022 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT) (OTCPink:RQHTF) (FSE:MHN2), a rapidly growing global...

Guidehouse Amplifies Health Segment with 4 New Leaders Former Hospital and State Health Executives Bring Strategic Expertise in Academic Medicine, Healthcare ESG, Hyperautomation, and Public Health

WASHINGTON, July 14, 2022 /PRNewswire/ -- Guidehouse, a leading global provider of consulting services to public sector and commercial clients,...

Alignment Healthcare to Enter Texas in 2023, Introducing Its Award-Winning Medicare Advantage Plans to Medicare-Eligible Adults in El Paso, Hudspeth Counties

ORANGE, Calif., July 14, 2022 (GLOBE NEWSWIRE) -- Alignment Healthcare (NASDAQ: ALHC), a tech-enabled Medicare Advantage company, today announced more details...

Press Release: Dupixent® (dupilumab) Phase 3 trial shows positive results in children 1 to 11 years of age with eosinophilic esophagitis

 Dupixent®(dupilumab) Phase 3 trial shows positive results in children 1 to 11 years of age with eosinophilic esophagitis First and...

error: Content is protected !!